Lecture one: Patient Assessment in Pharmacy Practice

33
Patient Care in Pharmacy Practice Anas Bahnassi PhD

description

An Introduction to pharmaceutical care and the role of patient assessment in providing optimal pharmaceutical care to your patients.

Transcript of Lecture one: Patient Assessment in Pharmacy Practice

Page 1: Lecture one: Patient Assessment in Pharmacy Practice

Patient Care in Pharmacy Practice

Anas Bahnassi PhD

Page 2: Lecture one: Patient Assessment in Pharmacy Practice

Anas Bahnassi PhD CDM CDE 2

Page 3: Lecture one: Patient Assessment in Pharmacy Practice

Patient-Centered Care

Care centered on patients’ needs and expectations

3Anas Bahnassi PhD CDM CDE

Page 4: Lecture one: Patient Assessment in Pharmacy Practice

Goals of Pharmaceutical Care

Cure of a disease

Elimination or reduction of a patient’s symptoms

Arresting or slowing of a disease process

Preventing a disease or symptomatology

4Anas Bahnassi PhD CDM CDE

Page 5: Lecture one: Patient Assessment in Pharmacy Practice

The central component of Pharmaceutical Care is: CARING ABOUT THE PATIENT.

5Anas Bahnassi PhD CDM CDE

Page 6: Lecture one: Patient Assessment in Pharmacy Practice

Pharmaceutical Care Process

Initiate relationship with

the patient or caregiver

Gather patient information

(subjective and objective) Assess info

(patient assessment)

Develop pharmaceutical

care plan

Complete InterventionImplement

follow-up

6Anas Bahnassi PhD CDM CDE

Page 7: Lecture one: Patient Assessment in Pharmacy Practice

Primary Elements of Pharmaceutical Care

The need of the society to address Drug

Related Problems (DRPs) A patient-centered

approach to meet this need

A practice based on “caring”

about and for patients

Responsibility for finding and

responding to the patient’s DRPs

7Anas Bahnassi PhD CDM CDE

Page 8: Lecture one: Patient Assessment in Pharmacy Practice

Pharmacist responsibility inPharmaceutical Care

To ensure that the patient’s drug therapy is appropriately indicated, the most effective available, the safest possible, the most convenient to take, and the most economical

To identify, resolve, and prevent any DRPs

To ensure that the patient’s therapeutic goals are met and that optimal health-related outcomes are attained.

8Anas Bahnassi PhD CDM CDE

Page 9: Lecture one: Patient Assessment in Pharmacy Practice

Drug Related ProblemsDRPs

– To resolve identified DTPs and to prevent future problems, pharmacist must understand the causes of these problems.

– The pharmacist must use a consistent, systematic and comprehensive process Pharmaceutical Care process

DRP is any undesirable event experienced by the patient that involves drug therapy and that actually (or potentially) interferes with a desired patient outcome.

9Anas Bahnassi PhD CDM CDE

Page 10: Lecture one: Patient Assessment in Pharmacy Practice

Common DRPs and Their causesDRP Type Possible CausesUnnecessary Drug Prescribed

No IndicationDuplicate Therapy

Wrong Drug Contraindications presentDrug not indicated for conditionsMore effective medic. availableDrug interactionIndication refractory to drugInappropriate dosage form

Dose Too Low Wrong doseInappropriate frequencyInappropriate durationIncorrect storageIncorrect administrationDrug interaction 10Anas Bahnassi PhD CDM CDE

Page 11: Lecture one: Patient Assessment in Pharmacy Practice

Common DRPs and Their causesDRP Type Possible CausesDose Too High Wrong dose

Inappropriate frequencyInappropriate durationIncorrect administrationDrug interaction

Adverse Drug Reactions Undesirable drug side effectAllergic reactionDrug interactionIncorrect administrationDose changed too quicklyUnsafe drug for the patient

11Anas Bahnassi PhD CDM CDE

Page 12: Lecture one: Patient Assessment in Pharmacy Practice

Common DRPs and Their causesDRP Type Possible CausesNoncompliance Cannot afford drug

Doesn’t understand instructions on how to take the drugCannot swallow/administer the drugDrug not available

Additional drug therapy Untreated conditionProphylactic therapySynergistic therapy

12Anas Bahnassi PhD CDM CDE

Page 13: Lecture one: Patient Assessment in Pharmacy Practice

Pharmaceutical CareProcess• Initiating a relationship with the patient

– patient bringing a new prescription to the pharmacy or asking about a nonprescription drug

• Pharmacist gathers all the pertinent information to evaluate the patient’s health and drug therapy appropriately– subjective information (patient complaints and

symptoms)– objective information (medication profile, vital signs,

or physical assessment data)

13Anas Bahnassi PhD CDM CDE

Page 14: Lecture one: Patient Assessment in Pharmacy Practice

Pharmaceutical CareProcess• Pharmacist assess the information and looks for

DRPs. • The DTPs are prioritized along with corresponding

goals and goal criteria, and documented in pharmaceutical care plan (PCP)

• Integral to the PCP, pharmacist develop the solutions to DRPs (= interventions).

• Develop the monitoring plan, which outlines factors that will determine attainment of the desired patient outcomes (BP measurement, lab data, talking with patient).

14Anas Bahnassi PhD CDM CDE

Page 15: Lecture one: Patient Assessment in Pharmacy Practice

Pharmaceutical CareProcess• Implement follow-up, which includes

implementing the monitoring plan (ex. Contact the patient to evaluate drug therapy compliance or drug side effects). Other follow up may include measuring vital signs or checking other physical or lab data.

NOTE:• Ideally, the patient should be involved throughout the entire

pharmaceutical care process.• After that plan has been implemented, the PCP recycles once again. The

pharmacist gather more data, assess the Px progress, and adjust the plan.

15Anas Bahnassi PhD CDM CDE

Page 16: Lecture one: Patient Assessment in Pharmacy Practice

For successfully incorporate Pharmaceutical Care into Practice, the Pharmacist

must have knowledge and skills in Patient

Assessment

16Anas Bahnassi PhD CDM CDE

Page 17: Lecture one: Patient Assessment in Pharmacy Practice

Patient Assessment

Patient assessment is the process through which the pharmacist evaluate the patient information (both objective and subjective) that was gathered from the patient and other sources (e.g. drug therapy profile, medical record, etc.)

17Anas Bahnassi PhD CDM CDE

Page 18: Lecture one: Patient Assessment in Pharmacy Practice

Patient AssessmentMeans:

Making decisions regarding:

1. The health status of the patient.

2. Drug therapy needs and problems.

3. Interventions that will resolve identified drug problems and future problems

4. Follow-up to ensure that patient outcomes are being met.

18Anas Bahnassi PhD CDM CDE

Page 19: Lecture one: Patient Assessment in Pharmacy Practice

Purpose of Patient Assessment:

A pharmacist cannot adequately provide pharmaceutical care without assessing patients.

• To identify, • To resolve, and • To prevent drug

related problems.

19Anas Bahnassi PhD CDM CDE

Page 20: Lecture one: Patient Assessment in Pharmacy Practice

Patient Assessment Should be done by:

• Asking a series of questions:• These questions will guide the pharmacist

through the assessment process.

• Assess the patient’s physical conditions:

• e g. skin abnormalities, obtainment of vital signs, peak flow readings, blood glucose levels, cholesterol values.

20Anas Bahnassi PhD CDM CDE

Page 21: Lecture one: Patient Assessment in Pharmacy Practice

Documentation:

• Provides a permanent record of patient information.

• Provides a permanent record and evidence of pharmaceutical care activities by the pharmacist.

• Communicates essential information to other pharmacists and health care professionals.

• Serves as a legal record of patient care that was provided.

• Provides back-up for billing purposes.

21Anas Bahnassi PhD CDM CDE

Page 22: Lecture one: Patient Assessment in Pharmacy Practice

Characteristics ofUseful Patient Records:• Information that is neat, organized, and able to be found

quickly.• Information that is easily understandable, so that any health

care professional can determine what the problems were, what actions were taken, and what follow-up is needed.

• Accurate subjective and objective information.• An assessment of the patient

information, focusing on DRPs.• A plan to resolve any problems that

were identified.• A plan for future follow-up to ensure that any problems are

resolved and that patient outcomes are met.22Anas Bahnassi PhD CDM CDE

Page 23: Lecture one: Patient Assessment in Pharmacy Practice

SOAP Note

23Anas Bahnassi PhD CDM CDE

Page 24: Lecture one: Patient Assessment in Pharmacy Practice

SOAP Note:

Subjective:Includes information that is given by the patient, family members, significant others, orcare givers.

• Complaint/symptoms in his/her own words

• Recent history that pertains tithose symptoms (history of present illness)

• Past medical history• Medication history, including

compliance & ADRs.• Allergies• Social and/or family history• Review of systems.

This type of information contains:

24Anas Bahnassi PhD CDM CDE

Page 25: Lecture one: Patient Assessment in Pharmacy Practice

SOAP Note:

Objective:Includes data that are obtained from the patient and that can be measured objectively.

• Vital signs.• Physical findings or physical

examination (if possible).• Laboratory test results (if

available).• Serum drug concentrations (if

available).• Various diagnostic test results (if

available).• Computerized medication profile

with refill information (if available).

This type of information contains:

25Anas Bahnassi PhD CDM CDE

Page 26: Lecture one: Patient Assessment in Pharmacy Practice

SOAP Note:

Assessment:

• Analyzes subjective and objective information.

• Determines the health status of the patient.• Is the patient experiencing a

DRP?• Have the patient’s outcomes

been met?• Provides the basis and rationale

for the plan.

The pharmacist:

26Anas Bahnassi PhD CDM CDE

Page 27: Lecture one: Patient Assessment in Pharmacy Practice

SOAP Note:

Plan:• Actions that were—or need to be—

taken to resolve any problems that have been identified.

• Follow-up to ensure that problems are actually corrected and that future problems do not develop.• The follow-up should include

monitoring parameters that need to be assessed as well as the interval for the next assessments

It involves:

27Anas Bahnassi PhD CDM CDE

Page 28: Lecture one: Patient Assessment in Pharmacy Practice

SOAP Note:

Plan:• Guidelines should be done with

the data at the time of the follow-up.

• Simplicity and reproducibility:• A colleague should be able to

read, interpret, and act on the plan if the pharmacist who documented the note is not available.

It involves:

28Anas Bahnassi PhD CDM CDE

Page 29: Lecture one: Patient Assessment in Pharmacy Practice

PharmaceuticalCare Plan:

Name: M.HGender: FDate: 9/2/2014Complaint: HTN.Drugs Used:Atenolol 25mg QD.Captopril 12.5mg BID

• The patient is picking up her Atenolol Rx.

• She feels:• Head lightness.• Weakness.• Impaired balance for 2 weeks.

• She has been taking Atenolol BID instead of QD this week.

Subjective:

29Anas Bahnassi PhD CDM CDE

Page 30: Lecture one: Patient Assessment in Pharmacy Practice

PharmaceuticalCare Plan:

Name: M.HGender: FDate: 9/2/2014Complaint: HTN.Drugs Used:Atenolol 25mg QD.Captopril 12.5mg BID

• The patient was staggering at the pharmacy counter.• Pulse is: 48 bpm.• Blood pressure is:

114/72 mm Hg112/70 mm Hg

Objective:

30Anas Bahnassi PhD CDM CDE

Page 31: Lecture one: Patient Assessment in Pharmacy Practice

PharmaceuticalCare Plan:

Name: M.HGender: FDate: 9/2/2014Complaint: HTN.Drugs Used:Atenolol 25mg QD.Captopril 12.5mg BID

• Bradycardia and hypotension-new-onset may be due noncompliance with atenololdosing.

Assessment:

31Anas Bahnassi PhD CDM CDE

Page 32: Lecture one: Patient Assessment in Pharmacy Practice

PharmaceuticalCare Plan:

Name: M.HGender: FDate: 9/2/2014Complaint: HTN.Drugs Used:Atenolol 25mg QD.Captopril 12.5mg BID

• Inform the patient to take atenolol once a day with breakfast and captopril 2 times daily as usual.

• For the follow-up a week later recheck pulse and blood pressure. • If still low, ask her to contact

her doctor and suggest lowering the dose atenolol.

Plan:

32Anas Bahnassi PhD CDM CDE

Page 33: Lecture one: Patient Assessment in Pharmacy Practice

Clinical Pharmacy VI:First AidAnas Bahnassi PhD CDM CDE

[email protected]

http://www.twitter.com/abpharm

http://www.facebook.com/pharmaprof

http://www.linkedin.com/in/abahnassi